Leerink Partners Initiates Coverage On Inari Medical with Market Perform Rating, Announces Price Target of $47
Portfolio Pulse from Benzinga Newsdesk
Leerink Partners has initiated coverage on Inari Medical with a Market Perform rating and set a price target of $47.
September 03, 2024 | 11:26 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Leerink Partners has initiated coverage on Inari Medical with a Market Perform rating and set a price target of $47, indicating a neutral outlook.
The Market Perform rating suggests that the stock is expected to perform in line with the market. The price target of $47 provides a specific valuation benchmark. This neutral rating and specific price target are important for investors considering the stock's potential performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100